Novel prognostic biomarkers for oral squamous cell carcinoma
Iowa Research Online (The University of Iowa) · 24.07.2023
DOI: 10.25820/etd.006958 ↗Kurz gefasst
Fachartikel in der Zeitschrift Iowa Research Online (The University of Iowa), erschienen am 24.07.2023. Verfasst von Wattawan Wongpattaraworakul.
Abstract (Originalsprache)
Oral squamous cell carcinoma (OSCC) is the most common malignancy in the head and neck region. Despite advanced treatments such as targeted therapies and immune checkpoint therapy, the five-year survival rate is slightly more than 50% after diagnosis. Patients' clinicopathological characteristics, including tumor size, lymph node metastasis, and distant metastasis (TNM stage), as well as tumor differentiation, perineural invasion, lymphovascular invasion, and bone invasion, are generally used as indicators to predict patient outcomes. However, these indicators may not accurately predict patient prognosis, and not all high-risk patients can be identified using them.
Schlagwörter
Zitieren
APA
Wongpattaraworakul, W. (2023). Novel prognostic biomarkers for oral squamous cell carcinoma. Iowa Research Online (The University of Iowa). https://doi.org/10.25820/etd.006958
Vancouver
Wongpattaraworakul W. Novel prognostic biomarkers for oral squamous cell carcinoma. Iowa Research Online (The University of Iowa). 2023. doi:10.25820/etd.006958
BibTeX
@article{Wongpattaraworakul2023,
author = {Wongpattaraworakul, Wattawan},
title = {Novel prognostic biomarkers for oral squamous cell carcinoma},
journal = {Iowa Research Online (The University of Iowa)},
year = {2023},
doi = {10.25820/etd.006958}
}
EUVIMED